Interests in associates (Details) - CHF (SFr) |
3 Months Ended | 6 Months Ended | 15 Months Ended | |||
|---|---|---|---|---|---|---|
Apr. 02, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
|
| General information | ||||||
| Beginning of the period | SFr 7,087,142 | |||||
| Share of the net loss for the period of Neurosterix's Group | SFr (1,231,845) | SFr (530,749) | (2,079,296) | SFr (530,749) | ||
| End of period | 5,007,846 | 5,007,846 | SFr 5,007,846 | |||
| Neurosterix US Holdings LLC | ||||||
| General information | ||||||
| Percentage of equity interest received | 20.00% | |||||
| Neurosterix Group | ||||||
| General information | ||||||
| Beginning of the period | 6,239,691 | 7,087,142 | 9,430,000 | |||
| Fair value of Neurosterix US Holdings LLC equity interest on April 2, 2024 | 9,428,400 | 9,428,400 | ||||
| Share of the net loss for the period of Neurosterix's Group | (1,231,845) | (530,749) | (2,079,296) | (530,749) | (4,300,000) | |
| End of period | SFr 9,430,000 | SFr 5,007,846 | SFr 8,897,651 | SFr 5,007,846 | SFr 8,897,651 | SFr 5,007,846 |